Novel combination of metformin & resveratrol alleviates fatty liver...

@davidasinclair
David Sinclair@davidasinclair
23 views Jan 10, 2025 ~1 min read
Advertisement
1
Novel combination of metformin & resveratrol alleviates fatty liver by activating autophagy via AMPK/SIRT1. Triple combo with rapamycin was the strongest effect link.springer.com/article/10.100…
Media image
2
This is a brief by interesting study of the effects of palmitic acid (a saturated long chain fatty acid) on human HepG2 liver cells. Have been on a rev - metformin combo for >8 years..
Media image
3
Nonalcoholic fatty liver disease (NAFLD) is a prevalent liver disorder that is associated with the accumulation of triglycerides (TG) in hepatocytes [liver cells]...
4
RSV-metformin reduced lipid accumulation and the expression of lipogenic [fat making] genes in palmitic acid (PA)-induced HepG2 cells. This combo protected HepG2 cells against PA-induced cell death by turning on autophagy. RSV-metformin induced autophagy [protein recycling. Look at the Resv-metformin-rapamycin combo…
Media image
5
Combo activated phospho AMP-activated protein kinase (p-AMPK), and Beclin-1 levels in HepG2 cells. Furthermore, SIRT1 inhibitor [Sirtinol] inhibited autophagy induced by RSV-metformin, which indicated the autophagy induction is SIRT1-dependent. This study demonstrated for the first time that RSV-metformin reduced hepatic steatosis by triggering autophagy via the cAMP/AMPK/SIRT1 signaling pathway. Worth studying in 🐁 and 🙋🏻‍♀️🙋🏻‍♂️! [end]
Media image
Actions
What You Can Do
  • Export as PDF or Markdown
  • Batch Export to Notion
  • Bookmark & Highlight
  • Screenshot Tweet
Create Free Account

Includes 7-day Premium trial

Advertisement